Oxidative Medicine and Cellular Longevity / 2016 / Article / Fig 2

Research Article

Kaempferol Attenuates Myocardial Ischemic Injury via Inhibition of MAPK Signaling Pathway in Experimental Model of Myocardial Ischemia-Reperfusion Injury

Figure 2

Effect of KMP on ((a1)–(d1)) Bcl-2 immunohistochemistry (20x; scale bar 100 μm); ((a2)–(d2)) Bax immunohistochemistry (20x; scale bar 100 μm); ((a3)–(d3)) Caspase-3 immunohistochemistry (20x; scale bar 100 μm); ((a4)–(d4)) TUNEL positivity (20x; scale bar 100 μm). ((a1)–(a4)) Sham; ((b1)–(b4)) ischemia-reperfusion control; ((c1)–(c4)) kaempferol 20 mg/kg/day + ischemia-reperfusion; ((d1)–(d4)) kaempferol 20 mg/kg/day per se.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.